Suppr超能文献

功能不良透析内瘘的血管内治疗:一项比较经桡动脉和传统经静脉入路的多中心回顾性分析

Endovascular Treatment of Malfunctioning Dialysis Fistulas: A Multicenter Retrospective Analysis Comparing Transradial and Conventional Transvenous Access.

作者信息

Minici Roberto, Venturini Massimo, Fontana Federico, Guzzardi Giuseppe, Torre Federico, Spinetta Marco, Coppola Andrea, Piacentino Filippo, Guerriero Pasquale, De Rosi Nicola, Apollonio Biagio, Franchin Marco, Giurazza Francesco, Brunese Luca, Laganà Domenico

机构信息

Radiology Unit, University Hospital Dulbecco, Catanzaro, Italy.

Diagnostic and Interventional Radiology Unit, ASST Settelaghi, Insubria University, Varese, Italy.

出版信息

Catheter Cardiovasc Interv. 2025 Jul;106(1):41-52. doi: 10.1002/ccd.31349. Epub 2024 Dec 26.

Abstract

BACKGROUND

Venous outflow is the favored access for endovascular management of dialysis fistulas. However, transradial access (TRA) offers advantages in specific clinical scenarios. The study aims to compare the efficacy, feasibility, and safety of TRA and transvenous access (TVA) in the endovascular management of malfunctioning dialysis fistulas, addressing the existing gap in comprehensive literature.

METHODS

A retrospective multi-center analysis included prospectively collected data (January 2021-November 2023) from patients undergoing endovascular management of malfunctioning dialysis fistulas with TRA. Control groups comprised patients with TVA.

RESULTS

Of 206 patients, 62 underwent TRA, and 144 underwent TVA. Baseline demographics showed a well-matched distribution. TRA exhibited longer cannulation times but similar procedural and fluoroscopy times. Technical success rates were high for both TRA (98.4%) and TVA (97.2%). Clinical success rates were comparable (96.8% vs. 95.8%). Postprocedure access flow rates and complications demonstrated no significant differences.

CONCLUSIONS

This study provides the first direct comparison of TRA and TVA in malfunctioning dialytic fistulas. While venous outflow remains the standard vascular access site for managing malfunctioning dialysis fistulas, TRA shows comparable efficacy, safety, and feasibility, making it a viable alternative in specific clinical contexts. Further studies are needed to confirm these findings and to determine the long-term durability of TRA.

摘要

背景

静脉流出道是透析瘘管血管腔内治疗的首选入路。然而,经桡动脉入路(TRA)在特定临床场景中具有优势。本研究旨在比较TRA和经静脉入路(TVA)在功能不良透析瘘管血管腔内治疗中的疗效、可行性和安全性,以填补现有综合文献中的空白。

方法

一项回顾性多中心分析纳入了前瞻性收集的数据(2021年1月至2023年11月),这些数据来自接受TRA治疗功能不良透析瘘管的患者。对照组包括接受TVA治疗的患者。

结果

206例患者中,62例接受了TRA,144例接受了TVA。基线人口统计学显示分布匹配良好。TRA的插管时间较长,但操作时间和透视时间相似。TRA(98.4%)和TVA(97.2%)的技术成功率都很高。临床成功率相当(96.8%对95.8%)。术后通路血流量和并发症无显著差异。

结论

本研究首次对TRA和TVA在功能不良透析瘘管中的应用进行了直接比较。虽然静脉流出道仍然是治疗功能不良透析瘘管的标准血管入路部位,但TRA显示出相当的疗效、安全性和可行性,使其在特定临床情况下成为一种可行的替代方案。需要进一步研究来证实这些发现,并确定TRA的长期耐用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d3e/12231155/eb6664a51f3c/CCD-106-41-g008.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验